Select Medical Holdings Corporation(SEM)Earnings, Financials & Key RatiosSelect Medical Holdings Corporation (SEM) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to maintain consistent free cash flow, highlighted by a -3.9% FCF margin in 2026Q1, suggests that current capital allocation strategies may be unsustainable.
Select Medical Holdings Corporation (SEM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Select Medical Holdings Corporation (SEM) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.36vs $0.43-16.3% | $1.4Bvs $1.4B+0.7% |
| Q1 2026 | Feb 19, 2026 | $0.16vs $0.23-30.4% | $1.4Bvs $1.4B+2.4% |
| Q4 2025 | Oct 30, 2025 | $0.23vs $0.18+27.8% | $1.4Bvs $1.4B-0.0% |
| Q3 2025 | Jul 31, 2025 | $0.32vs $0.28+14.3% | $1.3Bvs $1.3B+0.4% |
Recent stock market news and headlines for Select Medical Holdings Corporation (SEM)
MECHANICSBURG, Pa., June 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (the "Company" or "Select Medical," "we," "us," or "our") (NYSE: SEM) today announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A.
MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A.
Key metrics vs top competitors for Select Medical Holdings Corporation (SEM)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $16.51 | $2.05B | 13.99 | 5.12% | 2.68% | 7.25% | 1.54% | |
| $170.87 | $9.98B | 29.26 | 18.72% | 6.89% | 16.61% | — | |
| $31.92 | $2.94B | -2.63 | 5.04% | -32.84% | -40.92% | — | |
| $161.26 | $10.09B | 6.98 | 9.71% | 8.56% | 20.65% | — | |
| $17.17 | $2.25B | -28.15 | 6.24% | -2.28% | -2.15% | — | |
| $423.11 | $93.86B | 14.91 | 7.08% | 8.89% | — | — |
Select Medical Holdings Corporation (SEM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Select Medical Holdings Corporation (SEM) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 30, 2026·SEC
Apr 24, 2026·SEC
Mar 3, 2026·SEC
Get notified when SEM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Select Medical Holdings Corporation (SEM) stock FAQ — growth, dividends, profitability & financials explained
Select Medical Holdings Corporation (SEM) reported $5.52B in revenue for fiscal year 2025. This represents a 197% increase from $1.86B in 2005.
Select Medical Holdings Corporation (SEM) grew revenue by 5.1% over the past year. This is steady growth.
Yes, Select Medical Holdings Corporation (SEM) is profitable, generating $133.5M in net income for fiscal year 2025 (2.7% net margin).
Yes, Select Medical Holdings Corporation (SEM) pays a dividend with a yield of 1.54%. This makes it attractive for income-focused investors.
Select Medical Holdings Corporation (SEM) has a return on equity (ROE) of 7.3%. This is below average, suggesting room for improvement.
Select Medical Holdings Corporation (SEM) generated $117.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
